Product Code: GVR-1-68038-071-2
Exoskeleton Market Growth & Trends:
The global exoskeleton market size is anticipated to reach USD 1.25 billion in terms of revenue and 26,114 units in terms of volume by 2030 and is expected to grow at a CAGR of 16.6% in terms of revenue and 9.3% in terms of volume from 2024 to 2030, according to a new report by Grand View Research, Inc. Rapidly growing global geriatric population, increasing incidences of road accidents, and rising prevalence of stroke and spinal cord injuries are boosting the adoption of exoskeleton products and driving market growth. For instance, according to an article published by SingleCare Administrators in February 2023, globally, over 350 million individuals have arthritis, and 1 in 4 adults in the U.S. has arthritis.
Furthermore, the market is expected to witness the emergence of smarter & more competent exoskeletons through the integration of artificial intelligence and machine learning algorithms. For instance, in April 2022, Ottobock introduced the Ottobock Shoulder, a next-generation Paexo Shoulder exoskeleton that supports strenuous over-the-shoulder activities in production, logistics, handicraft, and maintenance. Thus, emergence of technologically advanced exoskeletons boosts market growth.
In addition, key players adopting diverse strategies such as new product launches, geographical expansion, partnerships, and collaborations, and a rise in R&D activities drive the market growth. In April 2022, ReWalk Robotics participated in the Human-Robot Interaction (HRI) Consortium, associated with the MAGNET incentive program under the Israel Innovation Authority. This initiative was expected to promote R&D collaborations and offer grants to renowned academic & research centers and private businesses developing advanced robotic technologies.
Moreover, exoskeletons have been used in various areas, including dry docks, factories, construction sites, surgical rooms, and warehouses. They are beneficial in reducing the burden of work. Thus, various benefits of exoskeletons are fueling market growth. Furthermore, with growing adoption and demand, it is expected that companies may buy millions of units for their workers to increase productivity and prevent musculoskeletal disorders over the forecast period, which is anticipated to result in increased quality of work.
Exoskeleton Market Report Highlights:
- Based on mobility, the mobile segment led the market with the largest revenue share of 62.1% and volume share of 63.1% in 2023, owing to multiple benefits associated with these products such as improving strength without restricting movement
- Based on technology, the powered segment led the market with the largest revenue share in 2023, owing to growing number of innovative product launches and an increase in product approvals from regulatory bodies
- Based on theextremity, the lower body segment led the market with the largest revenue share in 2023, due to rising incidence of lower body disabilities and an increasing number of road accidents
- Based on end use, the healthcare segment held the largest market share in 2023 owing to growing availability of adequate healthcare infrastructure and constant technological advancements
- North America region dominated the market in 2023 with the largest revenue share of 45.9% and volume share of 27.0% owing to growing disabled population, rising prevalence of spinal cord injuries, and presence of key players
Table of Contents
Chapter 1. Exoskeleton Market: Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Mobility
- 1.2.2. Technology
- 1.2.3. Extremity
- 1.2.4. Structure
- 1.2.5. End Use
- 1.2.6. Regional scope
- 1.2.7. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for Primary Interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for Primary Interviews in Latin America
- 1.4.5.5. Data for Primary Interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Exoskeleton Market: Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Mobility outlook
- 2.2.2. Technology outlook
- 2.2.3. Extremity outlook
- 2.2.4. Structure outlook
- 2.2.5. End-use outlook
- 2.3. Competitive Insights
Chapter 3. Exoskeleton Market: Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing incidence of spinal cord injury
- 3.2.1.2. Increasing incidence of musculoskeletal disorders
- 3.2.1.3. Technological advancements
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High development and maintenance costs
- 3.3. Exoskeleton Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Exoskeleton Market: Mobility Estimates & Trend Analysis
- 4.1. Mobility Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Exoskeleton Market by Mobility Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Mobile
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. Market estimates and forecasts 2018 to 2030 (Units)
- 4.4.2. Fixed/Stationary
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.2. Market estimates and forecasts 2018 to 2030 (Units)
Chapter 5. Exoskeleton Market: Technology Estimates & Trend Analysis
- 5.1. Technology Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Exoskeleton Market by Technology Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Powered
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.2. Market estimates and forecasts 2018 to 2030 (Units)
- 5.4.2. Non-powered
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.2. Market estimates and forecasts 2018 to 2030 (Units)
Chapter 6. Exoskeleton Market: Extremity Estimates & Trend Analysis
- 6.1. Extremity Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Exoskeleton Market by Extremity Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Upper body
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.1.2. Market estimates and forecasts 2018 to 2030 (Units)
- 6.4.2. Lower body
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2.2. Market estimates and forecasts 2018 to 2030 (Units)
- 6.4.3. Full body
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3.2. Market estimates and forecasts 2018 to 2030 (Units)
Chapter 7. Exoskeleton Market: Structure Estimates & Trend Analysis
- 7.1. Extremity Market Share, 2023 & 2030
- 7.2. Structure Dashboard
- 7.3. Global Exoskeleton Market by Structure Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4.1. Rigid exoskeletons
- 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 7.4.1.2. Market estimates and forecasts 2018 to 2030 (Units)
- 7.4.2. Soft exoskeletons
- 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2.2. Market estimates and forecasts 2018 to 2030 (Units)
Chapter 8. Exoskeleton Market: End Use Estimates & Trend Analysis
- 8.1. End Use Market Share, 2023 & 2030
- 8.2. Segment Dashboard
- 8.3. Global Exoskeleton Market by End Use Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.4.1. Healthcare
- 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 8.4.1.2. Market estimates and forecasts 2018 to 2030 (Units)
- 8.4.2. Military
- 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.2.2. Market estimates and forecasts 2018 to 2030 (Units)
- 8.4.3. Industry
- 8.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.4.3.2. Market estimates and forecasts 2018 to 2030 (Units)
Chapter 9. Exoskeleton Market: Regional Estimates & Trend Analysis
- 9.1. Regional Market Share Analysis, 2023 & 2030
- 9.2. Regional Market Dashboard
- 9.3. Global Regional Market Snapshot
- 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 9.5. North America
- 9.5.1. U.S.
- 9.5.1.1. Key country dynamics
- 9.5.1.2. Regulatory framework/ reimbursement structure
- 9.5.1.3. Competitive scenario
- 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Units)
- 9.5.2. Canada
- 9.5.2.1. Key country dynamics
- 9.5.2.2. Regulatory framework/ reimbursement structure
- 9.5.2.3. Competitive scenario
- 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6. Europe
- 9.6.1. UK
- 9.6.1.1. Key country dynamics
- 9.6.1.2. Regulatory framework/ reimbursement structure
- 9.6.1.3. Competitive scenario
- 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.2. Germany
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Regulatory framework/ reimbursement structure
- 9.6.2.3. Competitive scenario
- 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.3. France
- 9.6.3.1. Key country dynamics
- 9.6.3.2. Regulatory framework/ reimbursement structure
- 9.6.3.3. Competitive scenario
- 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.3.5. France Market Estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.4. Italy
- 9.6.4.1. Key country dynamics
- 9.6.4.2. Regulatory framework/ reimbursement structure
- 9.6.4.3. Competitive scenario
- 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.5. Spain
- 9.6.5.1. Key country dynamics
- 9.6.5.2. Regulatory framework/ reimbursement structure
- 9.6.5.3. Competitive scenario
- 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.6. Norway
- 9.6.6.1. Key country dynamics
- 9.6.6.2. Regulatory framework/ reimbursement structure
- 9.6.6.3. Competitive scenario
- 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.7. Sweden
- 9.6.7.1. Key country dynamics
- 9.6.7.2. Regulatory framework/ reimbursement structure
- 9.6.7.3. Competitive scenario
- 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Units)
- 9.6.8. Denmark
- 9.6.8.1. Key country dynamics
- 9.6.8.2. Regulatory framework/ reimbursement structure
- 9.6.8.3. Competitive scenario
- 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7. Asia Pacific
- 9.7.1. Japan
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Regulatory framework/ reimbursement structure
- 9.7.1.3. Competitive scenario
- 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7.2. China
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Regulatory framework/ reimbursement structure
- 9.7.2.3. Competitive scenario
- 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7.3. India
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Regulatory framework/ reimbursement structure
- 9.7.3.3. Competitive scenario
- 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7.4. Australia
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Regulatory framework/ reimbursement structure
- 9.7.4.3. Competitive scenario
- 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7.5. South Korea
- 9.7.5.1. Key country dynamics
- 9.7.5.2. Regulatory framework/ reimbursement structure
- 9.7.5.3. Competitive scenario
- 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Units)
- 9.7.6. Thailand
- 9.7.6.1. Key country dynamics
- 9.7.6.2. Regulatory framework/ reimbursement structure
- 9.7.6.3. Competitive scenario
- 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Units)
- 9.8. Latin America
- 9.8.1. Brazil
- 9.8.1.1. Key country dynamics
- 9.8.1.2. Regulatory framework/ reimbursement structure
- 9.8.1.3. Competitive scenario
- 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Units)
- 9.8.2. Mexico
- 9.8.2.1. Key country dynamics
- 9.8.2.2. Regulatory framework/ reimbursement structure
- 9.8.2.3. Competitive scenario
- 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.2.5. Mexico market estimates and forecasts 2018 to 2030 (USD Units)
- 9.8.3. Argentina
- 9.8.3.1. Key country dynamics
- 9.8.3.2. Regulatory framework/ reimbursement structure
- 9.8.3.3. Competitive scenario
- 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Units)
- 9.9. MEA
- 9.9.1. South Africa
- 9.9.1.1. Key country dynamics
- 9.9.1.2. Regulatory framework/ reimbursement structure
- 9.9.1.3. Competitive scenario
- 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Units)
- 9.9.2. Saudi Arabia
- 9.9.2.1. Key country dynamics
- 9.9.2.2. Regulatory framework/ reimbursement structure
- 9.9.2.3. Competitive scenario
- 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Units)
- 9.9.3. UAE
- 9.9.3.1. Key country dynamics
- 9.9.3.2. Regulatory framework/ reimbursement structure
- 9.9.3.3. Competitive scenario
- 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Units)
- 9.9.4. Kuwait
- 9.9.4.1. Key country dynamics
- 9.9.4.2. Regulatory framework/ reimbursement structure
- 9.9.4.3. Competitive scenario
- 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Units)
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company market share analysis, 2023
- 10.3.4. Ekso Bionics
- 10.3.4.1. Company overview
- 10.3.4.2. Financial performance
- 10.3.4.3. Product benchmarking
- 10.3.4.4. Strategic initiatives
- 10.3.5. Hocoma
- 10.3.5.1. Company overview
- 10.3.5.2. Financial performance
- 10.3.5.3. Product benchmarking
- 10.3.5.4. Strategic initiatives
- 10.3.6. Lockheed Martin Corporation
- 10.3.6.1. Company overview
- 10.3.6.2. Financial performance
- 10.3.6.3. Product benchmarking
- 10.3.6.4. Strategic initiatives
- 10.3.7. Suit X
- 10.3.7.1. Company overview
- 10.3.7.2. Financial performance
- 10.3.7.3. Product benchmarking
- 10.3.7.4. Strategic initiatives
- 10.3.8. Rex Bionics Plc.
- 10.3.8.1. Company overview
- 10.3.8.2. Financial performance
- 10.3.8.3. Product benchmarking
- 10.3.8.4. Strategic initiatives
- 10.3.9. RB3D
- 10.3.9.1. Company overview
- 10.3.9.2. Financial performance
- 10.3.9.3. Product benchmarking
- 10.3.9.4. Strategic initiatives
- 10.3.10. ReWalk Robotics
- 10.3.10.1. Company overview
- 10.3.10.2. Financial performance
- 10.3.10.3. Product benchmarking
- 10.3.10.4. Strategic initiatives
- 10.3.11. Cyberdyne, Inc.
- 10.3.11.1. Company overview
- 10.3.11.2. Financial performance
- 10.3.11.3. Product benchmarking
- 10.3.11.4. Strategic initiatives
- 10.3.12. ActiveLink (Panasonic Corporation)
- 10.3.12.1. Company overview
- 10.3.12.2. Financial performance
- 10.3.12.3. Product benchmarking
- 10.3.12.4. Strategic initiatives